Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).
about
A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseCan NASH be diagnosed, graded, and staged noninvasively?Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver diseaseThe Wide and Complex Field of NAFLD Biomarker Research: Trends.Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis.Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment.Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
P2860
Q28074377-5065A4E3-80AF-416F-A205-A179D2C37709Q30414504-B4ACF5CE-F7EB-4384-A8B0-B0D72E855AAAQ30451362-9572A295-D1DD-43EF-B41D-C05DAF7289CAQ34830398-11A4D0C4-6D55-4FBF-A41F-E3631798B434Q36218142-2FC58928-3261-494C-91CA-9A60C59874DCQ36577670-A77F7088-4700-4A3E-BED7-42B8AEF4252CQ36962085-2606599A-5769-4F71-8708-02AA1937CAB6Q37613375-6C49E59F-B8E8-4724-95E8-1BC8F49C8D2BQ38705139-AD952C72-4392-4263-A139-43AAB0B17CB0Q38739234-17833FED-DED6-4CB6-B543-D8BE9127F651Q39620167-0FCF82A4-E72D-499B-AB0C-35FE17816265Q40126822-CE0FBD18-3866-4A33-BA1E-4AE1B528E96AQ41706840-1745F4FF-7DC8-44EC-B0B1-1C9C43D9C770Q46680394-7DA8E508-2DDC-469A-931E-B595FD73CA83Q53095230-75BF7F54-ED29-4408-991D-3EB2B6E649A5Q59126498-1385811B-A374-448C-8DCA-CA3B5B5C6A8D
P2860
Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@ast
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@en
type
label
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@ast
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@en
prefLabel
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@ast
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@en
P2860
P50
P356
P1433
P1476
Validation of the BARD scoring ...... c fatty liver disease (NAFLD).
@en
P2093
Alina Chwist
Joanna Raszeja-Wyszomirska
P2860
P2888
P356
10.1186/1471-230X-10-67
P577
2010-06-28T00:00:00Z
P6179
1004710969